Stay updated on IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedThe MOR106 atopic dermatitis trial record is available with its study details, including its terminated status, trial design and outcomes, participant criteria, and study locations.SummaryDifference79%

- Check8 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0, while the study record continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision label also updates from v3.7.1 to v3.7.2.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study record page now displays a 403 Forbidden message, replacing the detailed study information, eligibility criteria, locations, and outcomes sections with a standard access-denied layout.SummaryDifference19%

- Check57 days agoChange DetectedA new page revision label appears, showing Revision: v3.7.0 in place of Revision: v3.6.6, indicating a minor update to the page template or metadata.SummaryDifference0.0%

Stay in the know with updates to IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.